An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat
Agree or disagree with the recent changes to mammography guidelines by the U.S. Preventive Services Task Force (USPSTF), one thing is clear – two sets of highly qualified experts can come to very different conclusions when looking at the same evidence. This holds big implications for provisions of health care reform like comparative effectiveness research (CER).
Baucus Reform Bill Keeps Comparative Effectiveness Out Of HHS
Comparative effectiveness provisions in Sen. Max Baucus' health care reform bill adhere largely to the stand-alone bill that the Finance Chair released earlier in the year, garnering support from...
June 10, 2009
PIPC Comments to the Federal Coordinating Council’s posting of its draft CER definition, prioritization criteria and strategic framework
PIPC Comments to Senate Finance Committee’s April 29 Policy Proposals Paper Entitled “Transforming the Health Care Delivery System: Proposals to Improve Patient Care and Reduce Health Care costs.”